Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @doctorpemm
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @doctorpemm
-
Prikvačeni tweet


Hot off the presses Our group’s new paper just out in @NEJM !!
#Tagraxofusp (SL-401) in Blastic Plasmacytoid Dendritic-Cell Neoplasm |#BPDCN | @lane_andy @DrHKantarjian Konopleva @LeukemiaMDA @DanaFarberhttps://www.nejm.org/doi/full/10.1056/NEJMoa1815105 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Amazing lecture on
#BPDCN by@doctorpemm
Very impressed by your enthusiastic and thoughtful way of presenting!
And by the outstanding work to lead the approval of tagraxofusp, the first drug approved for this rare disease! 
https://twitter.com/doctorpemm/status/1225225087374282754 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Thank you so much Dr. Pemmeraju! We are very fortunate to have great teachers, mentors, clinicians and researchers like you at the heart of our fellowship program
@doctorpemmPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
I am absolutely grateful to be part of an outstanding fellowship family
@MDAndersonNews@CancerMedMDA, with top-notch leadership who motivate us to be the best versions of ourselves, phenomenal mentors and the best cofellows one can ask for!@AlyssaRieberhttps://twitter.com/AlyssaRieber/status/1134953787012108289 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
One perk as
@ASTCT president - I get sneak
of our annual report!! Very proud of the 




accomplishments - 

to our volunteers, members and staffpic.twitter.com/4kXfYFpmiB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Characteristically energetic lecture by
@doctorpemm from@LeukemiaMDA on this often misunderstood disease. IKZF1 inactivation and BCL-2 dependence inform this HCVAD + Ven backbone.#bpdcn#orphanomorepic.twitter.com/oLkA5j09P3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
@LeukemiaMDA fellows with the one and only@doctorpemmhttps://twitter.com/doctorpemm/status/1225225087374282754 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Special shout out &
to Director of Fellowship Education Dr GGM @garciamanero & Co-Director@TapKadia for inviting me to speak at their successful & innovative Leukemia Fellows Lecture Series.Honored to present#BPDCN 101 to such a highly motivated & engaged group !#endcancerpic.twitter.com/37wAGZNc1w
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -


Hot off the presses! Use of CAR-Transduced Natural Killer Cells #NKcell in#CD19-Positive Lymphoid Tumors |@lab_rezvani &@wwierda@michaelwangmd@RichardChamplin@shpall https://www.nejm.org/doi/full/10.1056/NEJMoa1910607?query=featured_home … {Liu E/Rezvani K et al@NEJM Feb 6, 2020}#leusm#lymsm#bmtsm#endcancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Very nice paper from Dr Bastidas Torres et al (The Netherlands
+ Italy
collaboration) Whole‐genome analysis uncovers recurrent #IKZF1#Ikaros inactivation&aberrant cell adhesion in#BPDCN {Genes, Chromosomes and Cancer 2020 Wiley Online Library}https://onlinelibrary.wiley.com/doi/full/10.1002/gcc.22831 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
New blastic plasmacytoid dendritic cell neoplasm (
#BPDCN) treatment improves outlook for many patients [Jun 4, 2019] by@MDAndersonNews Staff Cancerwise http://ow.ly/XXgW30p5oSO cc@doctorpemmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wonderful talk by Dr Nitin Jain
@NitinJainMD at@LeukemiaMDA Grand Rounds this AM. Updates in CLL
including nice teaching slide showing a sampling of frontline phase 3 clinical trials in CLL field. #leusm#endcancerpic.twitter.com/2xLo912O8P
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
I am delighted to call attention to our partnership with MD Anderson that resulted in an IRB approved survey of 1,000 patients living with an MPN, myeloproliferative neoplasm. This video explains: http://bit.ly/MPNOnlineInfo
@MDAndersonNews#mpnsmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
When I started fellowship training
@MayoClinic, my friend@Rfonsi1 told me: You need a passing game (big research papers, RCTs), but also a running game (case reports, chart reviews, letters, reviews). Do both. Become good at it. This strategy has served me well.#medtwitterHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Another spectacular
@TXMedCenter#TMCsunset to appreciate this evening. A place of#Hope a moment to stop and appreciate the moment |#StopandSmellTheRoses#DoctorsAppreciatingSunsets#meded@MDAndersonNews@LeukemiaMDA#endcancerpic.twitter.com/3HQAQ7FkCI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Register for the latest clinical advancements in hematologic malignancies in a debate-driven, 2-day conference chaired by
@jaltmanmd,@jmikhaelmd and@JohnPLeonardMD!https://twitter.com/GreatDebatesHem/status/1220795780728000513 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Take a sneak peek into IACH prelimanry scientific program and join us at this exciting innovative meeting: https://iach2020.cme-congresses.com/program/ pic.twitter.com/mZdY1OKY0j
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
#MPNSMhttps://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(19)30236-4/fulltext#.Xjdel4YQ2_o.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Happy National Women’s Physician’s Day!! Too many amazing women to list!!!
#WomenInMedicine@acweyand@katiemcguinn@DrYasminKhakoo@darakass@DrOniBee@dr_uche_bee@TaniaJain11@hwang_susan@SusanProckopMD@DrDNFriedman@AMarshallMD@choo_ek@DrJenGunter@Carpeshannon01Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Thanks to a Phase II clinical trial led by our Dr. Loretta Nastoupil, Kelly Hale achieved remission just three months after being diagnosed with B-cell
#lymphoma: http://bit.ly/2RJxhS1#CancerMoonshot#endcancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naveen Pemmaraju, MD proslijedio/la je Tweet
Spent my 12th birthday in a transitional orphanage in
#Detroit Spent 6 years in a broken#FosterCare system Yet some people still believed in me Yet some people cared Yet God was good Now I get to serve suffering patients with cancer as a#GIonc and#pallonc See the unseenhttps://twitter.com/jmvpmd_phelan/status/1223438327233290240 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.